Ticker	Volume	Price	Price Delta
DJIA	15,112.20	-206.04	-1.35%
S&P 500	1,628.93	-22.88	-1.39%
Nasdaq	3,443.20	-38.98	-1.12%

Ticker

Volume

Price

Price Delta

DJIA

15,112.20

-206.04

-1.35%

S&P 500

1,628.93

-22.88

-1.39%

Nasdaq

3,443.20

-38.98

-1.12%

Ticker	Volume	Price	Price Delta
STOXX 50	2,683.98	-16.95	-0.63%
FTSE 100	6,348.82	-25.39	-0.40%
DAX	8,197.08	-32.43	-0.39%

Ticker

Volume

Price

Price Delta

STOXX 50

2,683.98

-16.95

-0.63%

FTSE 100

6,348.82

-25.39

-0.40%

DAX

8,197.08

-32.43

-0.39%

Ticker	Volume	Price	Price Delta
Nikkei	12,990.50	-254.71	-1.92%
Hang Seng	20,422.40	-564.44	-2.69%
S&P/ASX 200	4,753.90	-107.48	-2.21%

Ticker

Volume

Price

Price Delta

Nikkei

12,990.50

-254.71

-1.92%

Hang Seng

20,422.40

-564.44

-2.69%

S&P/ASX 200

4,753.90

-107.48

-2.21%

Novozymes Considering Multiple Enzyme Plants in Brazil

By Stephan Nielsen - 2012-05-31T13:28:13Z

(Corrects to remove price in first paragraph of story published May 29.)

Novozymes A/S (NZYMB), the Danish biotechnology company, may build multiple factories in Brazil to produce enzymes for processing sugar-cane residue into biofuels.

Novozymes will spend the next nine months evaluating potential locations, Sebastian Soderberg, the Bagsvaerd, Denmark-based company’s global head of cellulosic business and development and commercial relations, said today in an interview in Sao Paulo. The company may decide not to build any.

The company agreed May 23 to supply enzymes for GraalBio Investimentos SA’s ethanol plants in Brazil.

To contact the reporter on this story: Stephan Nielsen in Sao Paulo at snielsen8@bloomberg.net

To contact the editor responsible for this story: Will Wade at wwade4@bloomberg.net

Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.